Abstract
Irritable bowel syndrome is a frequent gastrointestinal disorder of unknown etiology. The serotonin transporter regulates the intensity and duration of serotonin signaling in the gut and is, therefore, an attractive candidate gene for irritable bowel syndrome. Previous studies investigating the 5-HTTLPR and Stin2 VNTR polymorphisms of the serotonin transporter have proved inconclusive. In this exploratory study we therefore expanded the search for a possible association of the serotonin transporter with irritable bowel syndrome to include not only the 5-HTTLPR and Stin2 VNTR length polymorphisms, but also the functional single nucleotide polymorphism rs25531. We genotyped 186 patients with irritable bowel syndrome and 50 healthy control subjects raging in age from 18 to 70 years. Carriers of the rare G allele of rs25531 had approximately threefold increased odds of irritable bowel syndrome compared with healthy controls (OR 3.3, 95% CI 1.1–9.6). Our findings suggest that further investigation of the possible role of the serotonin transporter in the etiology of IBS is warranted.
Similar content being viewed by others
Abbreviations
- SERT or 5-HTT:
-
Serotonin transporter
- 5-HTTLPR:
-
Serotonin transporter length polymorphic region, i.e. a 43 bp insertion–deletion polymorphism in the promoter region
- STin2 VNTR:
-
Serotonin transporter intron 2 variable number tandem repeat polymorphism
- rs25531:
-
Unique identifier for a single nucleotide polymorphism in the serotonin transporter gene promoter region
- IBS:
-
Irritable bowel syndrome
- PCR:
-
Polymerase chain reaction
- GI:
-
Gastrointestinal
- LD:
-
Linkage disequilibrium
References
Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123(6):2108–2131. doi:10.1053/gast.2002.37095.
Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am. 2005;34(2):189–204. doi:10.1016/j.gtc.2005.02.008.
Park MI, Camilleri M. Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment. Gastroenterol Clin North Am. 2005;34(2):305–317. doi:10.1016/j.gtc.2005.02.009.
Saito YA, Petersen GM, Locke GR III, Talley NJ. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005;3(11):1057–1065. doi:10.1016/S1542-3565(05)00184-9.
Crowell MD. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol. 2004;141(8):1285–1293. doi:10.1038/sj.bjp.0705762.
Mawe GM, Coates MD, Moses PL. Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment Pharmacol Ther. 2006;23(8):1067–1076. doi:10.1111/j.1365-2036.2006.02858.x.
Andresen V, Camilleri M. Irritable bowel syndrome: recent and novel therapeutic approaches. Drugs. 2006;66(8):1073–1088. doi:10.2165/00003495-200666080-00004.
Torres GE, Gainetdinov RR, Caron MG. Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci. 2003;4(1):13–25. doi:10.1038/nrn1008.
Ramamoorthy S, Bauman AL, Moore KR, et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA. 1993;90(6):2542–2546. doi:10.1073/pnas.90.6.2542.
Lesch KP, Balling U, Gross J, et al. Organization of the human serotonin transporter gene. J Neural Transm. 1994;95(2):157–162. doi:10.1007/BF01276434.
Heils A, Teufel A, Petri S, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem. 1996;66(6):2621–2624.
Wendland JR, Martin BJ, Kruse MR, Lesch KP, Murphy DL. Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry. 2006;11(3):224–226. doi:10.1038/sj.mp.4001789.
Yeo A, Boyd P, Lumsden S, et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut. 2004;53(10):1452–1458. doi:10.1136/gut.2003.035451.
Park JM, Choi MG, Park JA, et al. Serotonin transporter gene polymorphism and irritable bowel syndrome. Neurogastroenterol Motil. 2006;18(11):995–1000. doi:10.1111/j.1365-2982.2006.00829.x.
Pata C, Erdal ME, Derici E, Yazar A, Kanik A, Ulu O. Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol. 2002;97(7):1780–1784. doi:10.1111/j.1572-0241.2002.05841.x.
Kim HJ, Camilleri M, Carlson PJ, et al. Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut. 2004;53(6):829–837. doi:10.1136/gut.2003.030882.
Lee DY, Park H, Kim WH, Lee SI, Seo YJ, Choi YC. Serotonin transporter gene polymorphism in healthy adults and patients with irritable bowel syndrome. Korean J Gastroenterol. 2004;43(1):18–22.
Li YY, Nie YQ, Xie J, Tan HZ, Zhou YJ, Wang H. Serotonin transporter gene polymorphisms in irritable bowel syndrome and their impact on tegaserod treatment. Chung-Hua Nei Ko Tsa Chih Chin J Intern Med. 2006;45(7):552–555.
Saito YA, Locke GRIII, Zimmerman JM, et al. A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil. 2007;19(6):465–470. doi:10.1111/j.1365-2982.2007.00905.x.
Li Y, Nie Y, Xie J, et al. The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients. Dig Dis Sci. 2007;52(11):2942–2949. doi:10.1007/s10620-006-9679-y.
Wang BM, Wang YM, Zhang WM, et al. Serotonin transporter gene polymorphism in irritable bowel syndrome. Chung-Hua Nei Ko Tsa Chih Chin J Intern Med. 2004;43(6):439–441.
Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274(5292):1527–1531. doi:10.1126/science.274.5292.1527.
Hanna GL, Himle JA, Curtis GC, et al. Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder. Neuropsychopharmacology. 1998;18(2):102–111. doi:10.1016/S0893-133X(97)00097-3.
Little KY, McLaughlin DP, Zhang L, et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry. 1998;155(2):207–213.
Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet. 1999;88(1):83–87. doi:10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.0.CO;2-0.
Hu XZ, Lipsky RH, Zhu G, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet. 2006;78(5):815–826. doi:10.1086/503850.
Drossman DA. Rome-II: The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment: a Multinational Consensus. McLean, VA: Degnon Associates; 2000.
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. doi:10.1093/nar/16.3.1215.
Gelernter J, Kranzler H, Cubells JF. Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Hum Genet. 1997;101(2):243–246. doi:10.1007/s004390050624.
Gelernter J, Cubells JF, Kidd JR, Pakstis AJ, Kidd KK. Population studies of polymorphisms of the serotonin transporter protein gene. Am J Med Genet. 1999;88(1):61–66. doi:10.1002/(SICI)1096-8628(19990205)88:1<61::AID-AJMG11>3.0.CO;2-K.
Nakamura M, Ueno S, Sano A, Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry. 2000;5(1):32–38. doi:10.1038/sj.mp.4000698.
Lotrich FE, Pollock BG, Ferrell RE. Serotonin transporter promoter polymorphism in African Americans: allele frequencies and implications for treatment. Am J Pharmacogenomics. 2003;3(2):145–147. doi:10.2165/00129785-200303020-00007.
Coates MD, Mahoney CR, Linden DR, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology. 2004;126(7):1657–1664. doi:10.1053/j.gastro.2004.03.013.
Bellini M, Rappelli L, Blandizzi C, et al. Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron. Am J Gastroenterol. 2003;98(12):2705–2711. doi:10.1111/j.1572-0241.2003.08669.x.
Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology. 2006;130(1):34–43. doi:10.1053/j.gastro.2005.09.031.
Sakai K, Nakamura M, Ueno S, et al. The silencer activity of the novel human serotonin transporter linked polymorphic regions. Neurosci Lett. 2002;327(1):13–16. doi:10.1016/S0304-3940(02)00348-8.
Eckert D, Buhl S, Weber S, Jager R, Schorle H. The AP-2 family of transcription factors. Genome Biol. 2005;6(13):246. doi:10.1186/gb-2005-6-13-246.
Chen JJ, Li Z, Pan H, et al. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters. J Neurosci. 2001;21(16):6348–6361.
Van Kerkhoven LA, Laheij RJ, Jansen JB. Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26(7):979–986.
Acknowledgments
This study was supported by National Institute of Nursing Research Grants NIH NR01094, P30 NR04001, the NIH Office of Research in Women’s Health, and by resources from the Veterans Affairs Puget Sound Health Care System, Seattle, Washington.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kohen, R., Jarrett, M.E., Cain, K.C. et al. The Serotonin Transporter Polymorphism rs25531 Is Associated with Irritable Bowel Syndrome. Dig Dis Sci 54, 2663–2670 (2009). https://doi.org/10.1007/s10620-008-0666-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-008-0666-3